---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-23-001035"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2023-06-12T23:59:59+00:00"
generated_at: "2026-06-14T02:48:02.575545+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience dismisses CFO Gregory Downey; CEO assumes principal financial officer role

## Summary
- Gregory Downey dismissed as CFO effective June 6, 2023; company actively seeking replacement.
- Interim CFO services provided by Mike Shankman of NOW CFO; Shankman is CPA with MBA, healthcare experience.
- CEO Chris Bunka assumes role of principal financial officer; no additional compensation for Bunka.

## SEC filing metadata
- accession: 0001640334-23-001035
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2023-06-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001035/0001640334-23-001035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001035/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-23-001035
- JSON: https://secwatch.observer/filing/0001640334-23-001035.json
- Plain text: https://secwatch.observer/filing/0001640334-23-001035.txt

## Key facts
- Executive change
  Chris Bunka changed role as Principal Financial Officer at Lexaria Bioscience Corp..
  - Action: assumed
  - Role: Principal Financial Officer
  source text: The Company’s Chief Executive Officer, Chris Bunka, will assume the role of principal financial officer at this time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001035/0001640334-23-001035-index.htm
- Executive change
  Gregory Downey departed as Chief Financial Officer at Lexaria Bioscience Corp..
  - Action: dismissed
  - Role: Chief Financial Officer
  source text: Effective June 6, 2023, Mr. Gregory Downey was dismissed as the Company’s Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033423001035/0001640334-23-001035-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.